Updated

Milvue in numbers

Milvue is a French artificial intelligence company for radiology, based in Paris and Montreal. Its software equips more than 600 sites in 25 countries and runs 70 million analyses per year. In Europe, the Milvue Suite, which combines TechCare Alert for detection and TechCare Metrics for measurements, is a CE marked, Class IIa medical device. In the United States, TechCare Trauma and SmartChest are FDA 510(k) cleared. In Canada, SmartTrauma and TechCare Metrics are licensed by Health Canada. TechCare Report, the dictation and reporting app, is not a medical device.

Footprint

FigureWhat it measuresSourceDate
More than 600 sites equippedImaging sites equipped with Milvue software, cloud and on-premise, in the twelve months to October 31, 2026Company figures noteOctober 31, 2026
25 countriesCountries with at least one site installed, in the twelve months to October 31, 2026Company figures noteOctober 31, 2026
70 million analyses per yearAnalyses by Milvue's AI models, one per model and per image, October 2025 to September 2026Company figures noteOctober 31, 2026
2 officesHeadquarters in Paris (35 rue Vaugelas, 75015) and Milvue North America in Montreal (Suite 500, 355 rue Sainte-Catherine Ouest, H3B 1A5)MilvueOctober 2026

Regulatory status

TerritoryProductStatusDate
European UnionMilvue Suite (TechCare Alert, TechCare Metrics)Class IIa medical device within the meaning of EU Regulation MDR 2017/745, notified body BSI, CE 2797. ISO 13485 certified quality system (BSI, certificate MD 709839). All ages, from birth, outside critical care units; bone age from 0 to 18 years.In force
United StatesTechCare Trauma (aid to the detection of fractures and elbow joint effusion)FDA 510(k) cleared (K242171) as a Class II device (21 CFR 892.2090). Fractures from birth, depending on the body region; chest and ribs in adults; elbow joint effusion from age 2.January 17, 2025
United StatesSmartChest (triage of pneumothorax and pleural effusion, adults)FDA 510(k) cleared (K232410) as a Class II device (21 CFR 892.2080). Frontal chest X-ray, patients aged 18 and above.May 10, 2024
CanadaSmartTrauma, TechCare MetricsClass II medical devices licensed by Health Canada, manufacturer Milvue. SmartTrauma (MILVUE SUITE - SMARTTRAUMA, licence 108963), with no age limit; TechCare Metrics (MILVUE SUITE TECHCARE METRICS CA, licence 114126), from age 1, bone age from 1 to 18 years.SmartTrauma: February 23, 2023; TechCare Metrics: October 10, 2025
United KingdomFracture detectionNICE HTG739: one of four technologies that can be used in the NHS while more evidence is generatedJanuary 2025

Published clinical evidence

StudyPopulationResult for Milvue
Bousson et al., Academic Radiology, 2023, doi:10.1016/j.acra.2023.06.016Independent study led by Lariboisière Hospital, 1,210 consecutive emergency patients, 1,500 series, three commercial algorithms comparedThe highest fracture-detection accuracy in published independent head-to-head studies
van Leeuwen et al., Radiology, 2024, doi:10.1148/radiol.230981386 chest radiographs, 17 readers, 7 software productsLung nodule: AUC 0.86, statistically above the mean of the 17 readers (0.81, p = 0.04)
Parpaleix et al., European Journal of Radiology Open, 2023, doi:10.1016/j.ejro.2023.1004821,772 emergency patients, bone and chestCorrect in 90% of cases misread in the emergency department
Zerouali et al., Diagnostic and Interventional Imaging, 2023, doi:10.1016/j.diii.2023.03.003100 patients, median age 14Up to 70% less measurement time
Tanzilli et al., AI (MDPI), 2025, doi:10.3390/ai6070144105 adults, weight-bearing foot radiographsHallux valgus detected with 91% sensitivity
Reader studyReaders with and without the AI+22% reader sensitivity for fracture detection in adults, +20% in children under 22; 24% less reading time in adults
Performance testAI aloneAUC of 0.962 for fracture detection, adults and children

TechCare Report

FigureWhat it measuresSourceDate
1 million+ reportsReports produced with TechCare Report, RIS and PACS integrated version and web app combinedMilvue activity data2026
20 languagesDictation and report languages (French, English, German, Spanish, Italian, Dutch, Portuguese, Polish, Romanian, Czech, Danish, Swedish, Norwegian, Hungarian, Russian, Arabic, Mandarin, Hindi, Korean and Armenian)TechCare Report appOctober 2026
14 daysFull access on sign-up, no credit cardTechCare Report appOctober 2026
4 plansStarter free (up to 40 reports a month); Essential €19.99 a month or €199.90 a year; Pro €59.99 a month or €599.90 a year; Enterprise on quoteTechCare Report appOctober 2026

The Milvue Suite software, developed by the Milvue company, is a Class IIa medical device within the meaning of EU Regulation MDR 2017/745 - Notified Body: BSI, CE 2797. TechCare Alert and TechCare Metrics are the commercial designations of its SmartUrgences® and SmartXpert® modules. Read the instructions for use carefully.

TechCare Trauma, developed by Milvue, is FDA 510(k) cleared (K242171) as a Class II device (21 CFR 892.2090). It is intended to aid clinicians and does not replace their judgment. Rx only. See the IFU for indications and warnings. SmartChest, developed by Milvue, is FDA 510(k) cleared (K232410) as a Class II device (21 CFR 892.2080). It is intended to aid clinicians and does not replace their judgment. Rx only. See the IFU for indications and warnings.

SmartTrauma (MILVUE SUITE - SMARTTRAUMA, licence 108963) is a Class II medical device licensed by Health Canada. Manufacturer: Milvue. Read the instructions for use carefully. TechCare Metrics (MILVUE SUITE TECHCARE METRICS CA, licence 114126) is a Class II medical device licensed by Health Canada. Manufacturer: Milvue. Read the instructions for use carefully.

TechCare Report, report-drafting assistance software, is not a medical device.

Cite this page: Milvue, "Milvue in numbers", updated October 31, 2026, https://www.milvue.com/en/milvue-in-numbers/